Biom'Up S.A. announced the appointment of George Makhoul as Chief Commercial Officer with responsibility for the United States, effective January 31, 2019. Mr. Makhoul has a track record in commercializing medical products to hospitals and surgeons combined with a strong experience of the US hemostasis market. He will oversee all Biom'up sales and marketing activities in the US and work to strengthen the presence of the Company in this strategic market as the launch of its flagship product HEMOBLASTTM Bellows, a hemostatic product to control bleeding in a broad range of both traditional and laparoscopic surgical procedures, continues to gain market traction. He joins a team of veteran sales and marketing executives overseeing a nationwide network of more than 200 representatives. He will report directly to the Group CEO, Mr. Etienne Binant.